Tegean Capital Management, LLC Ibere Pharmaceuticals Transaction History

Tegean Capital Management, LLC

  • $81 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Dec 06, 2023
BUY
$9.77 - $9.84 $446,596 - $449,796
45,711 New
45,711 $448,000
Q1 2022

Nov 17, 2022
BUY
$9.69 - $9.81 $442,939 - $448,424
45,711 New
45,711 $448,000
Q4 2021

Nov 17, 2022
BUY
$9.68 - $9.77 $442,482 - $446,596
45,711 New
45,711 $444,000
Q4 2021

Feb 11, 2022
BUY
$9.68 - $9.77 $442,482 - $446,596
45,711 New
45,711 $444,000

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Tegean Capital Management, LLC Portfolio

Follow Tegean Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tegean Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tegean Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email